MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 447, doi. 10.1093/neuonc/noq197
- By:
- Publication type:
- Article
Works matching IS 15228517 AND DT 2011 AND VI 13 AND IP 4
Results: 16
1
2
Contents Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. NP, doi. 10.1093/neuonc/nor029
- Publication type:
- Article
3
Society news.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 456, doi. 10.1093/neuonc/nor020
- Publication type:
- Article
4
Are we ready to demystify age in glioblastoma? Or does older age matter in glioblastoma?
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 365, doi. 10.1093/neuonc/nor019
- By:
- Publication type:
- Article
5
Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 410, doi. 10.1093/neuonc/noq205
- By:
- Publication type:
- Article
6
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases*.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 428, doi. 10.1093/neuonc/nor005
- By:
- Publication type:
- Article
7
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 417, doi. 10.1093/neuonc/noq200
- By:
- Publication type:
- Article
8
Subscription Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. NP, doi. 10.1093/neuonc/nor028
- Publication type:
- Article
9
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 367, doi. 10.1093/neuonc/nor012
- By:
- Publication type:
- Article
10
Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 393, doi. 10.1093/neuonc/noq204
- By:
- Publication type:
- Article
11
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 437, doi. 10.1093/neuonc/noq198
- By:
- Publication type:
- Article
12
Cover Page.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. NP, doi. 10.1093/neuonc/nor026
- Publication type:
- Article
13
Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 401, doi. 10.1093/neuonc/noq206
- By:
- Publication type:
- Article
14
Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 376, doi. 10.1093/neuonc/noq192
- By:
- Publication type:
- Article
15
Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 384, doi. 10.1093/neuonc/noq193
- By:
- Publication type:
- Article
16
Editorial Board.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. NP, doi. 10.1093/neuonc/nor027
- Publication type:
- Article